Dipna Pharmachem Ltd.

12.61 -0.01 ▼-0.1%

05 December 2023, 04:01:00 PM
Volume: 51,000

Company Profile

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.dipnapharmachem.com
Market Cap 15.09 Cr.
Enterprise Value(EV) 33.04 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.76 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 16.55 Trailing Twelve Months Ending 2023-03
Industry PE 84.61 Trailing Twelve Months Ending 2023-03
Book Value / Share 20.35 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.62 Calculated using Price: 12.61
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.20 Cr. 11,970,000 Shares
FaceValue 10
About Dipna Pharmachem Ltd.
Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP.

Dipna Pharmachem Ltd. Delivery

Delivered Qty
Traded Qty

Dipna Pharmachem Ltd. Performance

1 Day
-0.08%
1 Week
+1.29%
1 Month
-12.00%
3 Month
-42.55%
6 Month
-23.58%
1 Year
-35.99%
2 Year
5 Year
10 Year

Dipna Pharmachem Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.24 6.78 11.39 4.32 101.02 6.99
Return on Capital Employed (%) 7.16 7.98 5.42 3.54 18.16 9.58
Return on Assets (%) 0.55 0.25 0.36 0.11 3.82 1.60

Dipna Pharmachem Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 1 1 2 24 25
Non Curr. Liab. 3 4 6 14 16
Curr. Liab. 11 14 15 21 29 39 64
Minority Int.
Equity & Liab. 11 14 18 25 36 78 104
Non Curr. Assets 0 0 0 0 0 0 0
Curr. Assets 11 14 18 25 36 78 104
Misc. Exp. not W/O
Total Assets 11 14 18 25 36 78 104

Dipna Pharmachem Ltd. Profit and Loss

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 17 20 31 31 73 100
Other Income 0 0 0 0 0 0
Total Income 17 20 31 31 73 100
Total Expenditure -16 -20 -30 -31 -71 -97
PBIDT 0 0 0 0 2 3
Interest 0 0 0 0 -1 -1
Depreciation 0 0 0 0 0
Taxation 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 1 1
Adjusted EPS 4 2 4 1 69 1

Dipna Pharmachem Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -3 -2 3 -21
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 3 3 -3 26
Net Change 0 0 0 5
Cash & Cash Eqvt 0 0 0 6

Dipna Pharmachem Ltd. Shareholding Pattern

3 Qtrs 2022-09 (%) 2023-03 (%) 2023-09 (%)
Promoter 66.56 66.56 57.19
Public 33.44 33.44 42.81
Depository Receipts 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00

Dipna Pharmachem Ltd. Announcements

Fri, 01 Dec 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dipna Keyur Shah
Tue, 28 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dipna Keyur Shah
Fri, 03 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dipna Keyur Shah

Dipna Pharmachem Ltd. Technical Scans

Tue, 05 Dec 2023
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Dipna Pharmachem Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 337,451.73 2,960.10 +17.0%
Redington Ltd. 12,992.11 166.20 +3.1%
Honasa Consumer Ltd. 11,706.76 363.85 -5.1%
MMTC Ltd. 7,678.50 51.19 -0.9%
Lloyds Enterprises Ltd. 5,503.22 43.26 +5.0%
Landmark Cars Ltd. 3,198.86 774.00 +0.6%
Optiemus Infracom Ltd. 2,908.41 339.00 -2.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-09 138.06 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-09 10.46 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 363.85 -5.1%
MMTC Ltd. Consolidated 2023-09 44.10 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-09 73.87 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-09 41.47 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-09 65.23 339.00 -2.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-09 9.20 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-09 1.88 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 18.41 363.85 -5.1%
MMTC Ltd. Consolidated 2023-09 5.31 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-09 3.83 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-09 6.33 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-09 7.54 339.00 -2.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-03 0.45 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 363.85 -5.1%
MMTC Ltd. Consolidated 2023-03 0.14 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 0.45 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 0.14 339.00 -2.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-03 22.66 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 363.85 -5.1%
MMTC Ltd. Consolidated 2023-03 247.70 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 24.15 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 339.00 -2.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-03 22.66 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 363.85 -5.1%
MMTC Ltd. Consolidated 2023-03 247.70 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 24.15 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 339.00 -2.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-03 79,376.78 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 363.85 -5.1%
MMTC Ltd. Consolidated 2023-03 3,528.18 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 3,382.35 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 1,173.88 339.00 -2.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 2,960.10 +17.0%
Redington Ltd. Consolidated 2023-03 1,439.39 166.20 +3.1%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 363.85 -5.1%
MMTC Ltd. Consolidated 2023-03 1,562.27 51.19 -0.9%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 43.26 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 85.10 774.00 +0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 41.88 339.00 -2.1%

Dipna Pharmachem Ltd. FAQ's

What is Dipna Pharma. share price?

Can I buy Dipna Pharma. shares now?

What is the Market Cap of Dipna Pharma.?

What are the key metrics to analyse Dipna Pharma.?

What is the 52 Week High and Low of Dipna Pharma.?

What is the trend of Dipna Pharma. share price?